Hostname: page-component-7479d7b7d-8zxtt Total loading time: 0 Render date: 2024-07-12T05:30:27.402Z Has data issue: false hasContentIssue false

Behavioral Symptoms as Predictor Factor of Disease Progression Across Different Neurocognitive Disorders. A Longitudinal Study

Published online by Cambridge University Press:  23 March 2020

H. Santamaría García
Affiliation:
Pontificia Universidad Javeriana, Psiquiatría, Bogotá, Colombia
J.M. Santacruz Escudero
Affiliation:
Universidad Javeriana, Psychiatry, Bogotá, Colombia
D. Matallana
Affiliation:
Javeriana, Instituto envejecimiento, Bogota, Colombia
A. Ibañez
Affiliation:
Instituto neurociencia Cognitiva y Traslacional INCyT, Neurociencia Cognitiva, Buenos Aires, Argentina

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background

Previous works highlight the importance of neurocognitive symptoms over cognitive and functional dependency in neurocognitive disorders. However, little is known regarding to what extent presence of neuropsychiatric symptoms predicts disease progression, cognitive and functional impairments in behavioral variant frontotemporal dementia (bvFTD) and in Alzheimer dementia.

Methods

We performed two different evaluations (T1 and T2) with 3 years of difference in a group of bvFTD (n = 18), AD (n = 20) and controls (n = 22). Neuropsychological, clinical and cognitive correlates were measured in each time T1 and T2. By using different multiple regression models, we explored if behavioral symptoms (measured by Columbia, Yesavage at T1) predict disease progression as measured by changes over T1 and T2 in cognitive (MoCA, IFS, and clock figure) and functional dependency (Lawton).

Results

Behavioral symptoms, in particular depression, psychosis, apathy and disihinibition were factors able to predict cognitive and functional progression in bvFTD. By contrast, regression model revealed that depression and insomnia were behavioral factors able to predict progression in AD.

Conclusion

Neuropsychiatric symptoms are crucial to predict disease progression in bvFTD and AD patients in differentiated ways. Our results suggest tha tracking early behavioral symptoms in neurocognitive disorders playing an important role in the early detection, disease tracking, and neuroanatomical specification of bvFTD, as well as in future research on potential disease-modifying treatments.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-Poster viewing: Old age psychiatry
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.